Explore / Clinical trial
Clinical trial

Ketamine for Suicidality in Bipolar Depression

New York State Psychiatric InstituteCompletedPhase 1Started Sep 1, 201316 enrolledUnited StatesNCT01944293

Abstract

This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from bipolar depression. The first drug, ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

MidazolamBipolar DisorderMajor Depressive EpisodeSuicidal IdeationSuicideTreatmentKetamine TreatmentBipolar DisorderMajor Depressive EpisodeSuicidal Ideation

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.